Generate Investment Management Ltd Buys Shares of 69,057 Danaher Corporation $DHR

Generate Investment Management Ltd purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 69,057 shares of the conglomerate’s stock, valued at approximately $13,093,000.

Several other hedge funds also recently made changes to their positions in DHR. JPL Wealth Management LLC acquired a new position in Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter valued at $26,000. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter valued at $26,000. Hilton Head Capital Partners LLC bought a new stake in Danaher during the 4th quarter worth about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd lifted its position in Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. The Goldman Sachs Group decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. UBS Group reduced their price target on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, Royal Bank Of Canada started coverage on Danaher in a research report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Stock Performance

Shares of DHR opened at $178.22 on Tuesday. The firm has a 50-day moving average of $179.32 and a 200-day moving average of $202.58. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market cap of $126.14 billion, a PE ratio of 34.47, a price-to-earnings-growth ratio of 2.26 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the business earned $1.88 EPS. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, equities analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.